Ami Bhatt, MD, the American College of Cardiology (ACC) chief innovation officer and adult congenital heart disease cardiologist at Mass General Hospital, discusses how to get physician acceptance to use artificial intelligence (AI). 

Lisa Mead, PSO executive director, Strategic Radiology, spoke at the Radiology Business Management Association (RBMA) 2022 meeting on radiology practices being prepared for the January 2023 deadline to have appropriate use criteria clinical decision support (AUC/CDS) software operational. 

RBMA’s 2022 Compensation Survey provided insights and benchmarks for executive and marketing leadership of member radiology groups. 

Linda Wilgus, CPA, CMPE, executive director and chief financial officer of Northwest Radiology Network and a past president of the Radiology Business Management Association (RBMA), explains the importance of the Physician Practice Information Survey CMS in calculating radiology reimbursements.

Ty Gluckman, MD, explains the main points of the American College of Cardiology (ACC) expert consensus on the cardiovascular consequences stemming from a COVID-19 infection.

Leslee Shaw, PhD, director of the Blavatnik Family Women’s Health Research Institute at Mount Sinai Hospital in New York and former president of the Society of Cardiovascular Computed Tomography (SCCT) and the American Society of Nuclear Cardiology (ASNC), explains the role of cardiac computed tomography (CT) in the recent 2021 chest pain guidelines.

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.